반응형
구분 | 보고서 (영문) |
제약/바이오/임상시험 | Exelixis's Cabometyx Advances mCRPC Treatment with Big Trial Validation Questions |
Arexvy’s Potential Label Expansion Will Provide Competitive Advantage in RSV Space | |
Novo Nordisk to Acquire CMO Giant Catalent for $16.5 Billion | |
New Hope for GSK’s Once Potential ADC Blockbuster Blenrep | |
Novo to Buy Catalent: The Backlash Begins | |
PCSK9 Inhibitor Alirocumab Proves Effective in Pediatric Familial Hypercholesterolemia | |
Tozorakimab Flunks Efficacy Endpoint in Phase IIb for DKD | |
질환별 | Artificial Intelligence Shows Improved Accuracy of Ovarian Cancer Diagnosis |
Ovarian Cancer: Opportunity Assessment and Forecast | |
Invasive Meningitis Cases Declined Post Vaccine Rollout in Western Australia | |
Age, Gender and Heart Failure: Understanding the Connection | |
Blood Tests for Alzheimer’s Could Significantly Improve Diagnosis in Patients | |
Premature Labor (PL): Competitive Landscape | |
컨퍼런스/심포지엄/학회/기타 | Alternative Therapies Are Needed to Combat the Impending Threat of AMR |
International Gaucher Alliance Marks 30th Year, Unveils 5-Year Strategic Plan to 2029 | |
Conference Organizing Tool – ECCO 2024 |
반응형
'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글
[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 (0) | 2024.03.15 |
---|---|
[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 (0) | 2024.03.15 |
[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서 (0) | 2024.03.15 |
[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 1.22.(월) (0) | 2024.01.24 |
[KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 (0) | 2024.01.08 |